DNA损伤修复基因多态性与乳腺癌放疗早期皮肤不良反应的多基因风险评分研究
PURPOSE: Genetic variations in DNA damage repair (DDR) genes may influence radiation therapy (RT)-induced acute normal tissue toxicity in patients with breast cancer.…
要点
- 5个DDR基因(ATM、CHEK1、ERCC2、RAD51C、TGFB1)的9个SNP与放疗早期皮肤不良反应显著相关。
- 多基因风险评分最高四分位组较低四分位组EASR风险显著升高(OR=8.64,95%CI 3.92-19.02)。
- PRS模型有潜力识别放疗皮肤不良反应高危人群,但需独立外部队列验证。
核心结论
- ATM、CHEK1、RAD51C、TGFB1和ERCC2基因的9个SNP与乳腺癌放疗诱导的早期皮肤不良反应相关。
- 多基因风险评分模型显示DDR基因多个SNP的联合效应可识别EASR高危人群,但需外部验证确定临床意义。
研究设计与样本
- 在416例完成放疗的乳腺癌患者中,使用肿瘤护理学会量表(0-6分)评估EASR,评分≥4分定义为放疗诱导的EASR。
- 对53个DDR基因的1968个SNP进行PLINK集合检验及后续单个SNP关联分析,并构建加权多基因风险评分模型。
主要发现
- 研究人群包括264例西班牙裔白人、86例黑人或非裔美国人、55例非西班牙裔白人和11例其他人群,共115例(27.6%)发生EASR。
- ATM rs61915066、CHEK1 rs11220184、RAD51C rs302877和rs405684、TGFB1 rs4803455和rs2241714、ERCC2 rs60152947、rs10404465和rs1799786被识别与EASR相关。
关键数值与推荐
- EASR定义:放疗完成时肿瘤护理学会量表评分≥4分。
临床怎么用
- 对于乳腺癌放疗患者,可考虑检测ATM、CHEK1、RAD51C、TGFB1和ERCC2基因的9个SNP并计算PRS以辅助风险分层。
- PRS高风险患者可能需要更密切的皮肤不良反应监测和预防性皮肤护理。
局限性
- 研究结果需要在独立外部队列中验证以确定这些预测生物标志物的临床意义。
- EASR评估仅在放疗完成时进行,未报告其他时间点的评估。
- 研究人群以西班牙裔白人为主,其他种族样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Genetic variations in DNA damage repair (DDR) genes may influence radiation therapy (RT)-induced acute normal tissue toxicity in patients with breast cancer. Identifying an individual or multiple single-nucleotide polymorphisms (SNPs) associated with RT-induced early adverse skin reactions (EASR) is critical for precision medicine in radiation oncology. METHODS AND MATERIALS: At the completion of RT, EASR was assessed using the Oncology Nursing Society scale (0-6) in 416 patients with breast cancer, and Oncology Nursing Society score ≥4 was considered RT-induced EASR. PLINK set-based tests and subsequent individual SNP association analyses were conducted to identify genes and SNPs associated with EASR among the 53 DDR genes and 1968 SNPs. A weighted polygenic risk score (PRS) model was constructed to ascertain the association between the joint effect of risk alleles and EASR. RESULTS: The study population consisted of 264 Hispanic whites, 86 blacks or African Americans, 55 non-Hispanic whites, and 11 others. A total of 115 patients (27.6%) developed EASR. Five genes (ATM, CHEK1, ERCC2, RAD51C, and TGFB1) were significantly associated with RT-induced EASR. Nine SNPs within these 5 genes were further identified: ATM rs61915066, CHEK1 rs11220184, RAD51C rs302877, rs405684, TBFB1 rs4803455, rs2241714, and ERCC2 rs60152947, rs10404465, rs1799786. In a multivariable-adjusted PRS model, patients in a higher quartile of PRS were more likely to develop EASR compared with patients in the lowest quartile (ORq2 vs.q1 = 1.94, 95% CI, 0.86-4.39; ORq3 vs.q1 = 3.46, 95% CI, 1.57-7.63; ORq4 vs.q1 = 8.64, 95% CI, 3.92-19.02; and Ptrend < .0001). CONCLUSIONS: We newly identified the associations between 9 SNPs in ATM, CHEK1, RAD51C, TGFB1, and ERCC2 and RT-induced EASR. PRS modeling showed its potential in identifying populations at risk. Multiple SNPs in DDR genes may jointly contribute to interindividual variation in RT-induced EASR. Validation in an independent external cohort is required to determine the clinical significance of these predictive biomarkers.
引用
- Lee E, Eum SY, Slifer SH, et al. Association Between Polymorphisms in DNA Damage Repair Genes and Radiation Therapy-Induced Early Adverse Skin Reactions in a Breast Cancer Population: A Polygenic Risk Score Approach. Int J Radiat Oncol Biol Phys. 2020. PMID: 32007367. doi:10.1016/j.ijrobp.2019.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。